Gregory Pugnet

Summary

Country: France

Publications

  1. ncbi request reprint Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life
    Gregory Pugnet
    National Referral Center for Rare Systemic Autoimmune Diseases, Hopital Cochin, AP HP, Universite Paris Descartes, Paris and Toulouse University Hospital, Internal Medicine Department, Toulouse, France
    Clin Exp Rheumatol 34:S54-9. 2016
  2. ncbi request reprint Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study
    Gregory Pugnet
    From the Laboratoire de Pharmacologie Médicale et Clinique, Faculte de Medecine, Université de Toulouse III INSERM, UMR1027 Caisse Nationale d Assurance Maladie des Travailleurs Salariés, Service Médical Midi Pyrénées Service de Pharmacologie Clinique, Centre d Investigation Clinique CIC 1436, and Service de Médecine Interne, Centre Hospitalier Universitaire CHU Toulouse, Toulouse, France
    J Rheumatol 43:2162-2170. 2016
  3. doi request reprint Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study
    Gregory Pugnet
    From the Faculté de Médecine, and the Laboratoire de Pharmacologie Médicale et Clinique, Université de Toulouse III INSERM, UMR1027 Service de Médecine Interne, and the Service de Pharmacologie Clinique, Centre Hospitalier Universitaire CHU Toulouse Caisse Nationale d Assurance Maladie des Travailleurs Salariés, Service Médical Midi Pyrénées, Toulouse, France G Pugnet, MD L Sailler, MD, PhD, Universite de Toulouse III, INSERM, UMR1027, Service de Medecine Interne, CHU Toulouse R Bourrel, MD, Caisse nationale d assurance maladie des travailleurs salariés, Service Médical Midi Pyrénées J L Montastruc, MD, PhD M Lapeyre Mestre, MD, PhD, Universite de Toulouse III, INSERM, UMR1027, Laboratoire de Pharmacologie Medicale et Clinique, Universite de Toulouse III, Service de Pharmacologie Clinique, CHU Toulouse
    J Rheumatol 42:316-22. 2015
  4. ncbi request reprint Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature
    G Pugnet
    Service de Médecine Interne salle Le Tallec, CHU Toulouse Purpan, Toulouse, France
    Clin Exp Rheumatol 31:S62-4. 2013
  5. doi request reprint Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients
    Ana Luisa Calich
    National Referral Center for Rare Systemic Autoimmune Diseases, Service de Medecine Interne, Hopital Cochin, Assistance Publique Hopitaux de Paris, Universite Paris Descartes, Paris, France Division of Rheumatology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
    J Autoimmun 50:135-41. 2014
  6. doi request reprint Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database
    Layla Saliba
    Service de Pharmacologie Medicale et Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, 37 Allees Jules Guesde, 31000, Toulouse, France
    Fundam Clin Pharmacol 30:162-71. 2016
  7. doi request reprint Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides
    Pierre Charles
    Cochin Hospital, AP HP, University of Paris Descartes, Department of Internal Medicine, 75014 Paris, France Institute Mutualiste Montsouris, Department of Internal Medicine, 75014 Paris, France
    Presse Med 42:1317-30. 2013
  8. doi request reprint Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients
    Pierre Charles
    Service de Medecine Interne, Institut Mutualiste Montsouris, 42 Boulevard Jourdan, 75014 Paris, France
    Rheumatology (Oxford) 53:532-9. 2014

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Rituximab versus azathioprine for ANCA-associated vasculitis maintenance therapy: impact on global disability and health-related quality of life
    Gregory Pugnet
    National Referral Center for Rare Systemic Autoimmune Diseases, Hopital Cochin, AP HP, Universite Paris Descartes, Paris and Toulouse University Hospital, Internal Medicine Department, Toulouse, France
    Clin Exp Rheumatol 34:S54-9. 2016
    ..To investigate the effects on health-related quality of life (HRQOL) and functional capability of rituximab vs azathioprine for ANCA-associated vasculitis (AAV) maintenance therapy...
  2. ncbi request reprint Predictors of Cardiovascular Hospitalization in Giant Cell Arteritis: Effect of Statin Exposure. A French Population-based Study
    Gregory Pugnet
    From the Laboratoire de Pharmacologie Médicale et Clinique, Faculte de Medecine, Université de Toulouse III INSERM, UMR1027 Caisse Nationale d Assurance Maladie des Travailleurs Salariés, Service Médical Midi Pyrénées Service de Pharmacologie Clinique, Centre d Investigation Clinique CIC 1436, and Service de Médecine Interne, Centre Hospitalier Universitaire CHU Toulouse, Toulouse, France
    J Rheumatol 43:2162-2170. 2016
    ..To identify predictors and protectors for cardiovascular hospitalization in a giant cell arteritis (GCA) population-based cohort...
  3. doi request reprint Is statin exposure associated with occurrence or better outcome in giant cell arteritis? Results from a French population-based study
    Gregory Pugnet
    From the Faculté de Médecine, and the Laboratoire de Pharmacologie Médicale et Clinique, Université de Toulouse III INSERM, UMR1027 Service de Médecine Interne, and the Service de Pharmacologie Clinique, Centre Hospitalier Universitaire CHU Toulouse Caisse Nationale d Assurance Maladie des Travailleurs Salariés, Service Médical Midi Pyrénées, Toulouse, France G Pugnet, MD L Sailler, MD, PhD, Universite de Toulouse III, INSERM, UMR1027, Service de Medecine Interne, CHU Toulouse R Bourrel, MD, Caisse nationale d assurance maladie des travailleurs salariés, Service Médical Midi Pyrénées J L Montastruc, MD, PhD M Lapeyre Mestre, MD, PhD, Universite de Toulouse III, INSERM, UMR1027, Laboratoire de Pharmacologie Medicale et Clinique, Universite de Toulouse III, Service de Pharmacologie Clinique, CHU Toulouse
    J Rheumatol 42:316-22. 2015
    ..To investigate the potential association between statin use and giant cell arteritis (GCA) course...
  4. ncbi request reprint Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature
    G Pugnet
    Service de Médecine Interne salle Le Tallec, CHU Toulouse Purpan, Toulouse, France
    Clin Exp Rheumatol 31:S62-4. 2013
    ..PML should be strongly suspected whenever unusual central neurological manifestations appear in this context. No effective treatment is available, but immunosuppressants should be discontinued if possible...
  5. doi request reprint Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients
    Ana Luisa Calich
    National Referral Center for Rare Systemic Autoimmune Diseases, Service de Medecine Interne, Hopital Cochin, Assistance Publique Hopitaux de Paris, Universite Paris Descartes, Paris, France Division of Rheumatology, University of Sao Paulo School of Medicine, Sao Paulo, Brazil
    J Autoimmun 50:135-41. 2014
    ..Maintenance treatment with low doses of RTX in a routine time-based protocol was safe and associated with low rates of relapse on treatment. ..
  6. doi request reprint Tumor necrosis factor inhibitors added to nonbiological immunosuppressants vs. nonbiological immunosuppressants alone: a different signal of cancer risk according to the condition. A disproportionality analysis in a nationwide pharmacovigilance database
    Layla Saliba
    Service de Pharmacologie Medicale et Clinique, centre Midi Pyrénées de pharmacovigilance, de Pharmacoepidemiologie et d Informations sur le Medicament, 37 Allees Jules Guesde, 31000, Toulouse, France
    Fundam Clin Pharmacol 30:162-71. 2016
    ..No signal was detected for melanoma potentially related to the lack of power. The signal seems similar whatever the TNFi. ..
  7. doi request reprint Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides
    Pierre Charles
    Cochin Hospital, AP HP, University of Paris Descartes, Department of Internal Medicine, 75014 Paris, France Institute Mutualiste Montsouris, Department of Internal Medicine, 75014 Paris, France
    Presse Med 42:1317-30. 2013
    ....
  8. doi request reprint Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients
    Pierre Charles
    Service de Medecine Interne, Institut Mutualiste Montsouris, 42 Boulevard Jourdan, 75014 Paris, France
    Rheumatology (Oxford) 53:532-9. 2014
    ..Our study was undertaken to describe AAV clinical responses to rituximab used for remission-induction and/or maintenance therapy, assess rituximab's safety profile and evaluate French clinical practices...